Quick Answer
CV Sciences, Inc. reported Stockholders Equity of $1.47 million for fiscal year 2025.
CV Sciences, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $1.47M | -18.2% |
| 2024 | $1.79M | -38.2% |
| 2023 | $2.90M | +473.6% |
| 2022 | -$777.0K | -121.9% |
| 2021 | $3.54M | -68.4% |
| 2020 | $11.21M | -61.5% |
| 2019 | $29.15M | -3.2% |
| 2018 | $30.12M | +83.8% |
| 2017 | $16.38M | +24.0% |
| 2016 | $13.21M | -43.3% |
| 2015 | $23.29M | +10.5% |
| 2014 | $21.08M | +153.7% |
| 2013 | $8.31M | +12038952.2% |
| 2012 | -$69.00 | +99.8% |
| 2011 | -$38.1K | -268.0% |
| 2010 | $22.7K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.54M | -29.8% | -14.6% |
| June 30, 2025 | $1.80M | -28.1% | -4.7% |
| March 31, 2025 | $1.89M | -19.9% | +5.4% |
| December 31, 2024 | $1.79M | -38.2% | -18.1% |
| September 30, 2024 | $2.19M | -37.0% | -12.6% |
| June 30, 2024 | $2.51M | -35.6% | +6.2% |
| March 31, 2024 | $2.36M | -53.2% | -18.6% |
| December 31, 2023 | $2.90M | +473.6% | -16.6% |
- CV Sciences, Inc. showed a decrease of -18.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2010–2025 period, CV Sciences, Inc.’s stockholders equity has grown by 6374.1% (from $22.7 thousand to $1.47 million).
- The most recent figure is from CV Sciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: